JP2005525097A5 - - Google Patents

Download PDF

Info

Publication number
JP2005525097A5
JP2005525097A5 JP2003558219A JP2003558219A JP2005525097A5 JP 2005525097 A5 JP2005525097 A5 JP 2005525097A5 JP 2003558219 A JP2003558219 A JP 2003558219A JP 2003558219 A JP2003558219 A JP 2003558219A JP 2005525097 A5 JP2005525097 A5 JP 2005525097A5
Authority
JP
Japan
Prior art keywords
composition
cancerous
level
cells
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003558219A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005525097A (ja
JP4376629B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/000657 external-priority patent/WO2003057926A1/en
Publication of JP2005525097A publication Critical patent/JP2005525097A/ja
Publication of JP2005525097A5 publication Critical patent/JP2005525097A5/ja
Application granted granted Critical
Publication of JP4376629B2 publication Critical patent/JP4376629B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003558219A 2002-01-08 2003-01-08 癌性胸部細胞において差次的に発現された遺伝子産物およびその使用方法 Expired - Lifetime JP4376629B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34563702P 2002-01-08 2002-01-08
PCT/US2003/000657 WO2003057926A1 (en) 2002-01-08 2003-01-08 Gene products differentially expressed in cancerous breast cells and their methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009001171A Division JP2009142282A (ja) 2002-01-08 2009-01-06 癌性胸部細胞において差次的に発現された遺伝子産物およびその使用方法

Publications (3)

Publication Number Publication Date
JP2005525097A JP2005525097A (ja) 2005-08-25
JP2005525097A5 true JP2005525097A5 (enExample) 2006-02-23
JP4376629B2 JP4376629B2 (ja) 2009-12-02

Family

ID=23355844

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003558219A Expired - Lifetime JP4376629B2 (ja) 2002-01-08 2003-01-08 癌性胸部細胞において差次的に発現された遺伝子産物およびその使用方法
JP2009001171A Pending JP2009142282A (ja) 2002-01-08 2009-01-06 癌性胸部細胞において差次的に発現された遺伝子産物およびその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009001171A Pending JP2009142282A (ja) 2002-01-08 2009-01-06 癌性胸部細胞において差次的に発現された遺伝子産物およびその使用方法

Country Status (11)

Country Link
US (1) US20060141455A1 (enExample)
EP (2) EP1472375B1 (enExample)
JP (2) JP4376629B2 (enExample)
AT (1) ATE427363T1 (enExample)
AU (1) AU2003235791A1 (enExample)
CA (1) CA2472282A1 (enExample)
DE (1) DE60326931D1 (enExample)
ES (1) ES2323456T3 (enExample)
PT (1) PT1472375E (enExample)
SG (1) SG148035A1 (enExample)
WO (1) WO2003057926A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700359B2 (en) * 2000-06-02 2010-04-20 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells
MXPA05001933A (es) * 2002-08-19 2005-04-28 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores.
JP2007532111A (ja) * 2004-04-06 2007-11-15 ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 乳癌における標的としてのオーファン受容体チロシンキナーゼ
US7232808B2 (en) * 2004-08-02 2007-06-19 University Of Iowa Research Foundation Methods of inhibiting manganese-containing superoxide dismutase 2 (MnSOD)
GB2424886A (en) 2005-04-04 2006-10-11 Dxs Ltd Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations
US7694048B2 (en) * 2005-05-06 2010-04-06 Fotonation Vision Limited Remote control apparatus for printer appliances
AT502722B8 (de) * 2005-10-31 2009-08-15 Bmt Medizinische Forschung Und Verwendung des interferon induzierten gens 12 (isg 12, ifi 27) zur modulation transkriptioneller aktivitäten von nuklearen rezeptoren
US20080113349A1 (en) * 2006-11-03 2008-05-15 Pranvera Ikonomi Method for detecting the presence of mammalian organisms using specific cytochrome c oxidase I (COI) and/or cytochrome b subsequences by a PCR based assay

Family Cites Families (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4714681A (en) 1981-07-01 1987-12-22 The Board Of Reagents, The University Of Texas System Cancer Center Quadroma cells and trioma cells and methods for the production of same
US4474893A (en) 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
EP0216846B2 (en) 1985-04-01 1995-04-26 Celltech Limited Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
US4777127A (en) 1985-09-30 1988-10-11 Labsystems Oy Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
GB8702816D0 (en) 1987-02-07 1987-03-11 Al Sumidaie A M K Obtaining retrovirus-containing fraction
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
US5993829A (en) * 1987-04-23 1999-11-30 Bystryn; Jean-Claude Anti-cancer vaccine
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
US5124246A (en) 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5206152A (en) * 1988-04-08 1993-04-27 Arch Development Corporation Cloning and expression of early growth regulatory protein genes
US5010175A (en) 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
AP129A (en) 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
US4925648A (en) 1988-07-29 1990-05-15 Immunomedics, Inc. Detection and treatment of infectious and inflammatory lesions
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
EP0454781B1 (en) 1989-01-23 1998-12-16 Chiron Corporation Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
DE69034168T3 (de) 1989-03-21 2013-04-11 Vical, Inc. Expression von exogenen Polynukleotidsequenzen in Wirbeltieren
ATE144793T1 (de) 1989-06-29 1996-11-15 Medarex Inc Bispezifische reagenzien für die aids-therapie
EP1645635A3 (en) 1989-08-18 2010-07-07 Oxford Biomedica (UK) Limited Replication defective recombinant retroviruses expressing a palliative
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
DE69133566T2 (de) * 1990-01-12 2007-12-06 Amgen Fremont Inc. Bildung von xenogenen Antikörpern
NZ237464A (en) 1990-03-21 1995-02-24 Depotech Corp Liposomes with at least two separate chambers encapsulating two separate biologically active substances
US5252296A (en) 1990-05-15 1993-10-12 Chiron Corporation Method and apparatus for biopolymer synthesis
US5149655A (en) 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
RU2142467C1 (ru) 1990-07-27 1999-12-10 Чирон Диагностикс Корпорейшн Полинуклеотиды, способ их получения, гибридизационный анализ нуклеиновой кислоты
AU667460B2 (en) 1990-10-05 1996-03-28 Medarex, Inc. Targeted immunostimulation with bispecific reagents
AU8727291A (en) 1990-10-29 1992-06-11 Cetus Oncology Corporation Bispecific antibodies, method of production, and uses thereof
JP3337214B2 (ja) 1990-12-20 2002-10-21 アーチ・ディベロップメント・コーポレーション 電離線による遺伝子発現の調節
GB9103974D0 (en) * 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments
WO1992019973A1 (en) * 1991-04-26 1992-11-12 Surface Active Limited Novel antibodies, and methods for their use
DE69233013T2 (de) 1991-08-20 2004-03-04 The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
WO1993010218A1 (en) 1991-11-14 1993-05-27 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Vectors including foreign genes and negative selective markers
GB9125623D0 (en) 1991-12-02 1992-01-29 Dynal As Cell modification
FR2685346B1 (fr) 1991-12-18 1994-02-11 Cis Bio International Procede de preparation d'arn double-brin, et ses applications.
WO1993014778A1 (en) 1992-01-23 1993-08-05 Vical, Inc. Ex vivo gene transfer
CA2131528C (en) 1992-03-05 2004-07-13 Philip E. Thorpe Methods and compositions for targeting the vasculature of solid tumors
FR2688514A1 (fr) 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
JPH07507689A (ja) 1992-06-08 1995-08-31 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 特定組織のターゲティング方法及び組成物
JPH09507741A (ja) 1992-06-10 1997-08-12 アメリカ合衆国 ヒト血清による不活性化に耐性のあるベクター粒子
GB2269175A (en) 1992-07-31 1994-02-02 Imperial College Retroviral vectors
CA2592997A1 (en) 1992-12-03 1994-06-09 Genzyme Corporation Pseudo-adenovirus vectors
AU6818094A (en) 1993-04-22 1994-11-08 Depotech Corporation Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
JP3532566B2 (ja) 1993-06-24 2004-05-31 エル． グラハム，フランク 遺伝子治療のためのアデノウイルスベクター
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
EP0694070B1 (en) 1993-09-15 2002-04-10 Chiron Corporation Recombinant alphavirus vectors
US6015686A (en) * 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
JP3875990B2 (ja) 1993-10-25 2007-01-31 カンジ，インコーポレイテッド 組換えアデノウイルスベクターおよび使用方法
NZ276305A (en) 1993-11-16 1997-10-24 Depotech Corp Controlled release vesicle compositions
US5578832A (en) * 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5631734A (en) * 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
WO1995030763A2 (en) 1994-05-09 1995-11-16 Chiron Viagene, Inc. Retroviral vectors having a reduced recombination rate
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5985660A (en) 1994-06-15 1999-11-16 Systemix, Inc. Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
WO1997027317A1 (en) 1996-01-23 1997-07-31 Affymetrix, Inc. Nucleic acid analysis techniques
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6974666B1 (en) 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
WO1996017072A2 (en) 1994-11-30 1996-06-06 Chiron Viagene, Inc. Recombinant alphavirus vectors
US5599695A (en) * 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
US5804162A (en) 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5811097A (en) 1995-07-25 1998-09-22 The Regents Of The University Of California Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
US5654173A (en) * 1996-08-23 1997-08-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
AU2189397A (en) 1996-02-08 1997-08-28 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
AU2998597A (en) 1996-05-06 1997-11-26 Chiron Corporation Crossless retroviral vectors
US5846536A (en) 1996-10-04 1998-12-08 The Regents Of The University Of California Restoration of normal phenotype in cancer cells
US6197543B1 (en) * 1997-10-28 2001-03-06 Incyte Pharmaceuticals, Inc. Human vesicle membrane protein-like proteins
EP1100523A4 (en) 1998-08-07 2005-02-02 Gen Hospital Corp TREATMENT OF CENTRAL NERVOUS SYSTEM ISCHEMIA OR TRAUMATISM WITH POLYPEPTIDES OF THE EPIDERMAL GROWTH FACTOR TYPE
US6844325B2 (en) * 1998-12-28 2005-01-18 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
EP1140141A2 (en) 1998-12-31 2001-10-10 Chiron Corporation Methods for treating cancer and for mediating chemotaxis of dendritic cells
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
WO2001007611A2 (en) 1999-07-26 2001-02-01 Genentech, Inc. Novel polynucleotides and method for the use thereof
US7700359B2 (en) * 2000-06-02 2010-04-20 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells
AU2001270118A1 (en) 2000-08-24 2002-03-04 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US7705120B2 (en) * 2001-06-21 2010-04-27 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer

Similar Documents

Publication Publication Date Title
CA2688477C (en) Multigene prognostic assay for lung cancer
NL2007467C2 (en) Compositions and methods for detecting cancer metastasis.
JP2006500949A5 (enExample)
JP2009502115A5 (enExample)
JP2007506426A5 (enExample)
EP1937837A2 (en) Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
JP2009502116A5 (enExample)
JP2010259438A5 (enExample)
US20160053327A1 (en) Compositions and methods for prediction of clinical outcome for all stages and all cell types of non-small cell lung cancer in multiple countries
JP2008512984A5 (enExample)
JP2005537007A5 (enExample)
JP2005525097A5 (enExample)
Lissa et al. HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients
JP2011517406A (ja) 重症の又は持続型の喘息の評価及び治療のためのマーカー及び方法
AU2012275323B2 (en) Somatic mutations in ATRX in brain cancer
Carinci et al. Genetic portrait of mild and severe lingual dysplasia
KR20110089577A (ko) Ｐｎａ 기반의 실시간 ｐｃｒ 클램핑을 이용한 ｂｒａｆ 돌연변이 검출 방법 및 키트
US20240417808A1 (en) Gene signatures for cancer characterization and treatment
KR20230171926A (ko) 암의 예후 예측용 마커 조성물, 이를 이용한 암의 예후예측 방법 및 암의 치료 방향 결정을 위한 정보 제공 방법
WO2005121360A3 (en) Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients
JP2004503238A5 (enExample)
JP2005504830A5 (enExample)
Ishikawa et al. Gene expression profile changes correlating with radioresistance in human cell lines
WO2020141213A1 (en) Transpochimeric gene trancripts (tcgts) as cancer biomarkers
JP2009523004A5 (enExample)